
Alectinib 150 mg Capsule is a targeted anticancer medicine used for the treatment of ALK-positive non-small cell lung cancer (NSCLC). It works by blocking the abnormal ALK protein, helping to slow or stop the growth and spread of cancer cells.
| Manufacturer | Roche Products India |
| Generic Name | Alectinib |
| Strength | 150mg |
| Pack size | 56 Capsules |
| Used For | Non-small cell lung cancer (NSCLC) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 Capsules | $1,250 | £925 | A$1,741 | ₱78,363 | د.ت3,638.75 | ₩1,673,875 | lei 5,659 | HK$9,803 | RM5,085 | ฿41,275 | S$1,584 | د.إ4,591.25 | ر.س4,693.75 | ر.ق4,551.25 | د.ك381.250 |
Alectinib is a targeted therapy that blocks the ALK (anaplastic lymphoma kinase) protein, which drives the growth of certain lung cancers. By inhibiting this abnormal protein, it stops cancer cell growth and spread.
Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.